Seres Therapeutics, Inc(NASDAQ:MCRB) 
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that ...
Website: http://www.serestherapeutics.com
Founded: 2010
Full Time Employees: 108
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 13.60
H 14.00
L 12.60
C 12.80
V 1,089,891
10EMA 12.80
20EMA 12.80
60EMA 12.80
120EMA 12.80
250EMA 12.80